<DOC>
	<DOCNO>NCT02389595</DOCNO>
	<brief_summary>The purpose research study develop vaccine Human immunodeficiency virus ( HIV ) , disease cause AIDS people , . The investigator look virus similar HIV animal . Since virus similar HIV , blood human expose HIV test see immune system recognize HIV prevent infection . HIV target immune system attack certain T cell call CD4+ T cell . There part AIDS virus help virus infect cell part help immune system prevent viral infection activate protective T-cells fight HIV . Different T-cell population important vaccine act `` effector '' work part immune system recognize fight HIV infection . When effector T cell activate appropriate `` protective '' part ( ) virus either block HIV reproducing kill HIV infect cell . By find common protective part human animal AIDS virus , investigator hope make vaccine help immune system prevent HIV infection avoid part attack CD4+ T cell may worsen HIV infection select part stimulate effector T cell fight HIV infection .</brief_summary>
	<brief_title>A T Cell-based HIV Vaccine</brief_title>
	<detailed_description>As participant study blood drawn perform .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female subject 18 65 year old HIV positive Persons immune disease would result autoimmunity aberrant immune response ( subject undergone chemotherapy within past year ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>vaccine</keyword>
	<keyword>T cell</keyword>
</DOC>